Delighted to share our collaborative work of a randomized clinical trial in @JIDJournal of a combined HIV reservoir-targeting drugs-NAD, auranofin, DC therapy-leading to cases of prolonged post-ART viral control #HIVCure w/ @unifesp@WCM_ID@WCMResearch
https://t.co/SA72XSeQRI
Our new review in #CurrentOpinions in HIV/AIDS discusses new knowledge on underlying molecular disease mechanisms impacting people aging with HIV. Also examined are studies on effective therapeutics to improve geriatric HIV care. @WCM_ID@ThomasPremeaux
https://t.co/7HWam1Lyp1